申请人:3M Innovative Properties Company
公开号:US08143270B2
公开(公告)日:2012-03-27
1H-Imidazo ring systems (e.g., imidazopyridines, imidazoquinolines, imidazonaphthyridines, 6,7,8,9-tetrahydro imidazoquinolines and imidazonaphthyridines) with an amino substituent at the 2-position, pharmaceutical compositions containing these compounds, methods of making the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
本发明公开了在2位具有氨基取代基的1H-咪唑环系(例如咪唑吡啶、咪唑喹啉、咪唑萘啉、6,7,8,9-四氢咪唑喹啉和咪唑萘啉)及其制药组合物、制备上述化合物的方法、中间体以及这些化合物的用途,包括作为免疫调节剂,调节动物的细胞因子生物合成,用于治疗包括病毒和肿瘤疾病在内的疾病。